Olmesartan medoxomil is a medication prescribed to treat high blood pressure [1]. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs) [2].
How does olmesartan work to lower blood pressure?
Olmesartan medoxomil works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels [1]. By preventing this narrowing, the blood vessels relax and widen, which lowers blood pressure [1].
What are the different forms or brands of olmesartan?
Olmesartan medoxomil is available under the brand name Benicar [3]. Generic versions of olmesartan medoxomil are also available [4].
What is the typical dosage of olmesartan?
Dosages for olmesartan medoxomil are individualized based on the patient's response and tolerance [1]. It is usually taken once daily [1].
What are the potential side effects of taking olmesartan?
Common side effects of olmesartan medoxomil can include dizziness, headache, fatigue, and upper respiratory tract infections [5]. More serious side effects, though less common, can include severe allergic reactions and a rare but serious intestinal condition called sprue-like enteropathy [6].
How long does it take for olmesartan to start working?
The blood pressure-lowering effects of olmesartan medoxomil can be seen within a few weeks of starting treatment [1].
What happens if I miss a dose of olmesartan?
If a dose of olmesartan medoxomil is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed. It is important not to double up on doses [1].
Can olmesartan be used during pregnancy?
Olmesartan medoxomil is generally not recommended for use during pregnancy, as it can cause harm to the developing fetus [1]. Patients who are pregnant or plan to become pregnant should discuss alternative treatment options with their healthcare provider [1].
What drugs are similar to olmesartan?
Other ARBs that are similar to olmesartan medoxomil include losartan, valsartan, and irbesartan [2]. These drugs work through a similar mechanism to lower blood pressure [2].
When does the patent for olmesartan expire?
Information on specific patent expiry dates for olmesartan medoxomil can be found on patent tracking websites such as DrugPatentWatch.com [7].
Who manufactures olmesartan?
The original brand-name medication, Benicar, was manufactured by Daiichi Sankyo [3]. Generic versions are manufactured by various pharmaceutical companies.
Are there any clinical studies or data available for olmesartan?
Numerous clinical trials have been conducted to evaluate the efficacy and safety of olmesartan medoxomil in treating hypertension [8]. These studies have demonstrated its effectiveness in reducing blood pressure and cardiovascular events [8].
What are the risks associated with olmesartan use?
Besides the potential side effects mentioned earlier, a significant risk associated with olmesartan medoxomil is the development of sprue-like enteropathy, a condition characterized by severe chronic diarrhea and weight loss [6]. This condition requires immediate medical attention and discontinuation of the drug [6].
Can olmesartan be combined with other blood pressure medications?
Olmesartan medoxomil is often prescribed in combination with other antihypertensive agents, such as diuretics, to achieve better blood pressure control [1].
*
**Sources
1. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil
2. https://www.drugpatentwatch.com/drug-classes/angiotensin-ii-receptor-blockers-arb
3. https://www.drugpatentwatch.com/brand/benicar
4. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil/generics
5. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil/side-effects
6. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil/rare-side-effects
7. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil/patents
8. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil/clinical-trials